Nonmedical Use of Prescription ADHD Stimulant Medications Among Adults in a Substance Abuse Treatment Population: Early Findings From the NAVIPPRO Surveillance System
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objective: To examine nonmedical use (NMU) of prescription ADHD stimulants among adults evaluated for substance abuse treatment. Method: 147,816 assessments from the National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO) system (10/01/2009 through 03/31/2012) examined NMU prevalence, routes of administration (ROA), and diversion sources. Results: Past 30-day NMU for prescription stimulants (1.29%) was significantly lower than that of prescription opioids (19.79%) or sedatives (10.62%). For stimulant products, NMU for Adderall was 0.62, followed by Adderall XR (0.42), Ritalin (0.16), Vyvanse (0.12), and Concerta (0.08); product differences likely have limited clinical relevance given the low estimates (<1%). Higher NMU per prescriptions was for Adderall (4.92), Ritalin (4.68), and Adderall XR (3.18) compared with newer formulations (Vyvanse 1.26, Concerta 0.89). Diversion source was mainly family/friends with no differences between products; swallowing whole was the most frequent ROA. Conclusion: Prescription stimulant NMU was low compared with other prescription medications among individuals assessed for substance abuse problems, with little difference among specific products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Zito, J. M. (2000) · JAMA · doi:10.1001/jama.283.8.1025 · Cited by 863 · cited 2×
“The number of youth and adult patients receiving pharmacologic ADHD treatment is growing (Cohen, Jhung & Budnitz, 2006; Fortuna et al., 2010; Safer, Zito, & Fine, 1996; Spencer et al., 2005; Zito et al., 2000), and treatment includes a diverse range of psycho-stimulants.”
BackgroundMisuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815a56f1 · Cited by 824 · cited 1×
“…with the 2010 NSDUH survey (SAMHSA, 2011) and other studies (Barrett, Darredeau, Bordy, & Pihl, 2005; Cassidy et al., 2012; McCabe, Cranford, et al., 2006; Novak et al., 2007; Wilens et al., 2008), while a dealer was the source of the drugs for approximately 24% of those abusing ADHD stimulants.”
BackgroundSpencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., Mick, E., Aleardi, M., Herzig, K., & Faraone, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.043 · Cited by 385 · cited 1×
“The number of youth and adult patients receiving pharmacologic ADHD treatment is growing (Cohen, Jhung & Budnitz, 2006; Fortuna et al., 2010; Safer, Zito, & Fine, 1996; Spencer et al., 2005; Zito et al., 2000), and treatment includes a diverse range of psycho-stimulants.”
BackgroundMedical Use, Illicit Use and Diversion of Prescription Stimulant Medication
McCabe, S. E., Teter, C. J., & Boyd, C. J. (2006) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2006.10399827 · Cited by 305
Initial validation of a computer-administered Addiction Severity Index: The ASI–MV.
Bultler, S. F., Budman, S. H., Goldman, R. J., Newman, F. J., Beckley, K. E., Trottier, D., & Cacciola, J. S. (2001) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.15.1.4 · Cited by 127 · cited 2×
“Despite acknowledged limitations of the ASI-MV system, it is important to highlight the relatively large number of assessments available, a wide geographic distribution of assessment sites, and use of a validated method of direct questioning of the individuals (Butler et al., 2001; Butler et al., 2009).”
MethodRole of monoamine transporters in mediating psychostimulant effects
Riddle, E. L., Fleckenstein, A. E., & Hanson, G. R. (2005) · The AAPS Journal · doi:10.1208/aapsj070481 · Cited by 117
Cited by
Faraone, S. V., Rostain, A. L., Montano, C. B., Mason, O., Antshel, K. M., & Newcorn, J. H. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.06.012 · Cited by 225
A Systematic Review of the Safety of Lisdexamfetamine Dimesylate
Coghill, D. R., Caballero, B., Sorooshian, S., & Civil, R. (2014) · CNS Drugs · doi:10.1007/s40263-014-0166-2 · Cited by 89
“12) [63].”
Shopping behavior for ADHD drugs: results of a cohort study in a pharmacy database
Cepeda, M. S., Fife, D., Berwaerts, J., Yuan, Y., & Mastrogiovanni, G. (2014) · Drugs in R&D · doi:10.1007/s40268-014-0058-4 · Cited by 17
Metadata
- Authors
- Cassidy, T. A., McNaughton, E. C., Varughese, S., Russo, L., Zulueta, M., & Butler, S. F.
- Venue
- Journal of Attention Disorders
- Publisher
- SAGE Publications
- Published
- 2013-07-30
- Volume
- 19
- Issue
- 4
- Pages
- 275-283
- ISSN
- 1087-0547 (ISSN-L)
- 1557-1246
- OpenAlex
- W2100483406
- Cited by
- 37
- References
- 6
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonmedical Use of Prescription ADHD Stimulant Medications Among Adults in a Substance Abuse Treatment Population: Early Findings From the NAVIPPRO Surveillance System. https://app.cochat.ai/papers/10.1177/1087054713493321
- The paper
- Cassidy, T. A., McNaughton, E. C., Varughese, S., Russo, L., Zulueta, M., & Butler, S. F. (2015). Nonmedical Use of Prescription ADHD Stimulant Medications Among Adults in a Substance Abuse Treatment Population: Early Findings From the NAVIPPRO Surveillance System. Journal of Attention Disorders. https://doi.org/10.1177/1087054713493321
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.